108 related articles for article (PubMed ID: 21724525)
21. Amplification of the telomerase RNA component gene in the process of human esophageal carcinogenesis.
Chen Q; Wang X; Ru Y; Chen S; Gao S; Xing L; Mi J; Wang Y; Xiao Z; Feng X
Tohoku J Exp Med; 2011 Jun; 224(2):99-104. PubMed ID: 21597243
[TBL] [Abstract][Full Text] [Related]
22. Study on the correlation between hTREC and HPV load and cervical CINI/II/III lesions and cervical cancer.
He H; Pan Q; Pan J; Chen Y; Cao L
J Clin Lab Anal; 2020 Jul; 34(7):e23257. PubMed ID: 32100923
[TBL] [Abstract][Full Text] [Related]
23. The Clinicopathological Correlations of hTERC Amplification with Esophageal Squamous Cell Precursor Lesions.
Hu Y; Teng X; Wu L; Liu W; An J
Dig Dis Sci; 2019 Jan; 64(1):68-75. PubMed ID: 30311151
[TBL] [Abstract][Full Text] [Related]
24. [Molecular biological study on the overexpression of c-myc gene in uterine cervical carcinomas].
Tanimoto H; Nagai N; Fujimoto H; Ohta S; Ohama K
Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):566-70. PubMed ID: 1619315
[TBL] [Abstract][Full Text] [Related]
25. [Application of Van-Clear and xylene in the detection of cervical hTERC gene by fluorescence in situ hybridization].
Chen Z; Wang Y; Mi X; Chen A; Zhong S; Huang H; Xu X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 41(4):367-73. PubMed ID: 27241146
[TBL] [Abstract][Full Text] [Related]
26. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
Jenkins RB; Qian J; Lieber MM; Bostwick DG
Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
[TBL] [Abstract][Full Text] [Related]
27. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
Caraway NP; Khanna A; Dawlett M; Guo M; Guo N; Lin E; Katz RL
Gynecol Oncol; 2008 Jul; 110(1):37-42. PubMed ID: 18433848
[TBL] [Abstract][Full Text] [Related]
28. [Comparison between poly hydroxy acrylic acid and Van-clear replacing the traditional reagents to detect the cervical hTERC genes by adopting FISH technique].
Chen ZQ; Wang Y; Mi XJ; Chen A; Huang HY; Zhong SJ; Deng WT; Liu CF; Xu XM; Dai XZ
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 48(2):356-60. PubMed ID: 27080296
[TBL] [Abstract][Full Text] [Related]
29. [The possibility of viral etiology in cervical carcinogenesis].
Iwasaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):802-11. PubMed ID: 2172417
[TBL] [Abstract][Full Text] [Related]
30. Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization.
Ravaioli S; Tumedei MM; Amadori A; Puccetti M; Chiadini E; Bravaccini S
J Low Genit Tract Dis; 2017 Jan; 21(1):42-46. PubMed ID: 27611439
[TBL] [Abstract][Full Text] [Related]
31. Amplification of hTERT and hTERC genes in leukemic cells with high expression and activity of telomerase.
Nowak T; Januszkiewicz D; Zawada M; Pernak M; Lewandowski K; Rembowska J; Nowicka K; Mankowski P; Nowak J
Oncol Rep; 2006 Aug; 16(2):301-5. PubMed ID: 16820907
[TBL] [Abstract][Full Text] [Related]
32. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients.
Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y
Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657
[TBL] [Abstract][Full Text] [Related]
33. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
Nagai N
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
[TBL] [Abstract][Full Text] [Related]
34. Gain of human telomerase RNA gene is associated with progression of cervical intraepithelial neoplasia grade I or II.
Lan YL; Yu L; Jia CW; Wu YM; Wang SY
Chin Med J (Engl); 2012 May; 125(9):1599-602. PubMed ID: 22800828
[TBL] [Abstract][Full Text] [Related]
35. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
[TBL] [Abstract][Full Text] [Related]
36. Negative implication of C-MYC as an amplification target in esophageal cancer.
Huang XP; Rong TH; Wang JY; Tang YQ; Li BJ; Xu DR; Zhao MQ; Zhang LJ; Fang Y; Su XD; Liang QW
Cancer Genet Cytogenet; 2006 Feb; 165(1):20-4. PubMed ID: 16490593
[TBL] [Abstract][Full Text] [Related]
37. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
[TBL] [Abstract][Full Text] [Related]
38. c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance.
Schleger C; Verbeke C; Hildenbrand R; Zentgraf H; Bleyl U
Mod Pathol; 2002 Apr; 15(4):462-9. PubMed ID: 11950922
[TBL] [Abstract][Full Text] [Related]
39. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
[TBL] [Abstract][Full Text] [Related]
40. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.
Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U
Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
